Delivery Order 75N91019D00024-75N91020F00029
Active Awarded Last action
- Contract number
- 75N91020F00029
- Awardee
-
Leidos Biomedical Research Inc. UEI HV8BH9BPG8Y9 Part of Leidos Holdings, Inc.
- Awarding agency
-
National Cancer Institute
National Institutes of Health, Department of Health and Human Services
- Obligated
- $25,726,378
Award facts
- Contract value 100% obligated
- $25,726,378.00 Current and potential, with all options
- Completion date 68% complete
-
- Current, with exercised options
- Potential, with all options
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Cost Plus Fixed Fee
- Place of performance
- Frederick, MD 21703, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Terminate for Convenience | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $8,178,103 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Other Administrative Action | $0 | |
| Exercise an Option | $6,991,846 | |
| Other Administrative Action | $5,183,897 | |
| Other Administrative Action | $0 | |
| Original award | $5,372,532 |
Show all 11
About this award
This is a $25,726,378.00 cost-plus-fixed-fee delivery order contract awarded by the National Cancer Institute (NCI), part of the National Institutes of Health, to Leidos Biomedical Research Inc. The contract supports the implementation of the President's Department of Government Efficiency Cost Efficiency Initiative, with a period of performance through September 2029. The contract does not have a set-aside designation, indicating Leidos Biomedical Research's competitiveness in providing comprehensive biomedical research and facilities support services to federal agencies, particularly the NIH. Major subcontractors include Fred Hutchinson Cancer Center, Icahn School of Medicine at Mount Sinai, and Bruker Scientific LLC, providing specialized research services and advanced scientific equipment and maintenance.
Quick answers
Who was awarded contract 75N91020F00029?
75N91020F00029 was awarded to Leidos Biomedical Research Inc. by National Cancer Institute (National Institutes of Health) on September 21, 2020.
How much is contract 75N91020F00029 worth?
The government has obligated $25,726,378 on 75N91020F00029.
Is contract 75N91020F00029 an order under another contract?
Yes. 75N91020F00029 is a delivery order under 75N91019D00024, an indefinite delivery contract.
Was contract 75N91020F00029 competed?
The extent of competition for 75N91020F00029 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award